Warren Cresswell
M.B.A. from the University of Pittsburgh and B.A. in Chemistry from California State University, Northridge. Warren has over 25 years of experience in the diagnostics industry. He was previously CEO at Prometheus Labs, CEO at Microbiome Diagnostic Partners, and Vice President at Dako, leading the Asia Pacific Business Unit.
Current assignments: Board member at Demeter Sciences.
Holdings: 100,000 TO9, 24 000 stock options 23/26:1 and 8 000 stock options 23/26:2.
>4,500
Numbers of patients in studies
28
Publications
19
Pharma Projects